52 filings
Page 2 of 3
8-K
um3mgeay a2p
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
a9x0ot08
10 May 22
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
4:04pm
8-K
8u02w3
25 Apr 22
Results of Operations and Financial Condition
8:14am
8-K
vzi96sywe93 ypo2
3 Mar 22
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
4:02pm
8-K
qf7giyny
8 Nov 21
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
5x4t uy1t
12 Oct 21
Regulation FD Disclosure
9:19am
8-K
yg2j7
21 Sep 21
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
9:09am
8-K
3h1du 8txukjvhjmj5sb
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
nwm8cz
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
i0grenv
6 May 21
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:06am
8-K
0ia6mu3w n65ht
20 Apr 21
Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer
4:44pm
8-K
4r0 hl2tww
25 Feb 21
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
8:00am
8-K
4ugvvcluu7f
17 Nov 20
Departure of Directors or Certain Officers
5:13pm
8-K
2yn9vv2o2pqzasxs0
10 Nov 20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
8-K
676yrp0im 97
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
iug7wr0gkivu2 7q7m
11 Aug 20
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate Update
4:30pm
8-K
f6yyuk2nicm bkz
2 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
38sw0rt8fl
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
87bthju0s 1g
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
yudyg6ws08mysdee7
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm